Pharmacokinetics, Relative Bioavailability, and Safety of the SHR0302 Oral Solution and Tablets: A Single-Center, Randomized, Open-Label, Crossover (Two-Formulation, Two-Period) Phase I Trial in Healthy Chinese Volunteers

Gao X, Shen K, Tang D, Bai W, Wang J, Wang T, Wang X

Drug Design, Development and Therapy 2025, 19:8783-8792

Published Date: 26 September 2025